Remepy

Redefining medicine through Hybrid Drugs

New York, United States · Founded 2022 · $51.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2022
Business Model
B2B
Website
remepy.com
Total Funding
$51.0M
Last Round
$36.0M Series AAug 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 10 investors for this company. The full record is or through the API.

About

Remepy is redefining medicine through Hybrid Drugs, therapies that combine pharmaceutical treatments with targeted digital interventions. Remepy is pioneering a new category of therapy by combining pharmaceuticals with targeted digital interventions, with a mission to deliver more personalized, adaptive, and effective care - helping patients heal through the unified power of biology, behavior, and technology. The company is built by a team of scientists, technologists, physicians, and creators who believe the future of medicine is multidimensional.

Summary

Remepy is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $51.0M in total across 3 rounds, most recently a $36.0M Series A round in Aug 2026. Investors include TechAviv Founder Partners, NFX and fresh.fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AAug 2026
$36.0M

Sign up to see all 3 events

Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Hims and HersIPO

Telehealth platform providing personalized health and wellness treatments for men and women, cove...

San Francisco, United States501–1000Digital Health, E-Commerce
ConvertibleTotal funding$2.6BJan 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026
ByteDance

ByteDance is a Chinese technology company that utilizes AI to distribute content based on users' ...

Beijing, China10001+Social Media, Artificial Intelligence
Growth EquityTotal funding$6.1BOct 2018
Genesys

Genesys empowers more than 8,000 organizations worldwide with Genesys Cloud, an agentic AI experi...

Daly City, United States5001–10000Artificial Intelligence, SaaS
Growth EquityTotal funding$4.5BJul 2025
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Remepy on Indexed.vc
<a href="https://indexed.vc/companies/remepy"><img src="https://indexed.vc/api/badge/company/remepy" alt="Remepy on Indexed.vc" width="260" height="76" /></a>